Daiwa Securities Group’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-13
Closed 1366
2022
Q3
$0 Hold
13
﹤0.01% 1377
2022
Q2
$0 Hold
13
﹤0.01% 1403
2022
Q1
$0 Hold
13
﹤0.01% 1400
2021
Q4
$1K Buy
+13
New +$1K ﹤0.01% 1351